10.7 C
New York
Thursday, April 25, 2024

Credit Suisse Upgrades Thoratec To Outperform

Courtesy of Benzinga.

Related THOR
Thoratec Appoints D. Keith Grossman President And CEO
Benzinga's Top Downgrades

Analysts at Credit Suisse upgraded Thoratec (NASDAQ: THOR) from Neutral to Outperform.

The price target for Thoratec has been raised from $27.00 to $35.00.

Thoratec shares have dropped 30.46% over the past 52 weeks, while the S&P 500 index has surged 14.18% in the same period.

Thoratec’s shares fell 2.01%to close at $29.20 yesterday.

Latest Ratings for THOR

Date Firm Action From To
Nov 2014 Credit Suisse Upgrades Neutral Outperform
Nov 2014 Wells Fargo Upgrades Market Perform Outperform
Nov 2014 Bank of America Maintains Neutral

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

Posted-In: Credit SuisseUpgrades Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,319FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x